Sort
261,768 grants matching “gene therapy”
Identifying the mechanisms of leukemia progression
$1,077,000John D Crispino · St. Jude Children'S Research Hospital · R35 · FY2021 · CA
Integrating systems immunology with immunometabolism and cancer immunity
$1,077,000Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2025 · CA
Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage
$1,076,893Jeffery J Auletta · National Marrow Donor Program · U01 · FY2025 · AI
New targets against tuberculosis
$1,076,804Deborah T Hung · Broad Institute, Inc. · R01 · FY2021 · AI
Molecular profile of proviral reservoirs in HIV-infected drug users
$1,076,786Xu Yu · Massachusetts General Hospital · R61 · FY2019 · DA
Maintenance of Models of Human Hemophilia and VWD
$1,076,728Timothy Charles Nichols · Univ Of North Carolina Chapel Hill · R24 · FY2016 · HL
Gene Therapy for Metabolic Disorders
$1,076,684Chester B Whitley · University Of Minnesota · P01 · FY2007 · HD
Vaccine and Drug Combination Therapy for Human Cancers
$1,076,634James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Vaccine and radiation for the therapy of human cancers
$1,076,634James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
PRINT: Nanoparticles: "Calibration Quality" Nano-tools for Studying the Effect of
$1,076,600Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2014 · CA
Gene Therapy for Metabolic Disorders
$1,076,565Chester B Whitley · University Of Minnesota · P01 · FY2006 · HD
Therapeutic Strategies for the Management of HCV/HIV co- infection
$1,076,509Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Studies of Histone Functions in Chromatin; H2AX and DNA DSBs
$1,076,353William Bonner · Basic Sciences · Z01 · FY2007 · CA
Effect of diflunisal (IND68092) on familial amyloidosis
$1,076,155John L Berk · Boston University Medical Campus · R01 · FY2009 · NS
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
$1,076,143Debra L Friedman · Vanderbilt University Medical Center · UG3 · FY2021 · CA
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$1,075,984Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Neutralizing Botulinum Neurotoxin with Human Antibodies
$1,075,856Rae Lyn Burke · Sri International · U01 · FY2008 · AI
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients
$1,075,681Olivia M Martinez · Stanford University · U01 · FY2020 · AI
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia
$1,075,653Roy H Hamilton · University Of Pennsylvania · R01 · FY2025 · AG
Virus biology scientific research support component
$1,075,630Beatrice H Hahn · Duke University · UM1 · FY2017 · AI
HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)
$1,075,525Matthias Egger · Universitat Bern · R01 · FY2022 · AI
Chloride fluxes in organellar membranes
$1,075,499Joseph A Mindell · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Washington University PDX Development and Trial Center
$1,075,484Li Ding · Washington University · U54 · FY2024 · CA
Kansas PKD Research and Translation Core Center
$1,075,339James P Calvet · University Of Kansas Medical Center · P30 · FY2016 · DK
Kansas PKD Research and Translation Core Center
$1,075,339James P Calvet · University Of Kansas Medical Center · P30 · FY2018 · DK